Find CMO/CDMOs that produce:
Biologics
Category
Filters
Reset current filters
Selected filters:
Production region
Production scale
Qualifications
Follow us
CDMO-CMO
Plants in:
Established in: 1998
Production scale:
small
medium
large
Employees: 1000
Facilities with global regulatory compliance
Customized and Flexible Collaboration Models
End-to-end drug discovery
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2021
Production scale:
small
Employees: 19
API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides
Small quantity APIs to commercial scale
GMP and USFDA certification based on quantity, order, assignment.
All certificates
Replies quickly
CDMO-CMO
Leading in aerosol and transdermal drug delivery systems.
Expertise in both small molecule and biologic drug formulation.
Strong track record in bringing complex therapies to market.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 2016
Production scale:
medium
small
Low Volume high value API Fill and Finish Service
In-line monitoring, SKAN Isolators, Highly Experienced Staff
Capacity Available, Ready for your API
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2020
Production scale:
medium
Specialized in gene therapy and viral vector production.
Expertise in both clinical and commercial scale manufacturing.
Focus on quality, safety, and regulatory excellence in biologics.
All certificates
Replies slower than most
CDMO-CMO
Specialized in enzyme-based products and custom biocatalysis solutions.
Strong focus on sustainability and green chemistry in pharmaceutical manufacturing.
Innovative R&D for novel enzyme applications and process optimization.
All certificates
Replies slower than most
CDMO-CMO
Specialized in liquid and semi-solid pharmaceuticals manufacturing.
Nordic excellence in quality and reliability.
Flexible production capabilities catering to a wide range of batch sizes.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1980
Production scale:
medium
Employees: 30+
EU-GMP and DIN EN ISO 9001:2015
Pioneer in the fractionation of sheep plasma
Pure & sterile high-quality products
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2002
Production scale:
large
Specialized in biologics CDMO services with a focus on monoclonal antibodies.
Advanced facilities for clinical and commercial-scale manufacturing.
Strong commitment to quality and regulatory compliance.
All certificates
Replies slower than most
CDMO-CMO
Pioneering in advanced delivery technologies and development solutions.
Extensive global network ensuring supply chain resilience.
Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
CDMO-CMO
Expertise in cell therapy development and manufacturing.
Tailored solutions for autologous and allogeneic cell therapies.
Cutting-edge technology for scalable and efficient cell therapy production.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1881
Production scale:
large
Noted for excellence in blood products and biologics.
Committed to safety, quality, and regulatory compliance in healthcare.
Pioneering in research and development of blood-derived therapeutics.
All certificates
Replies slower than most
CDMO-CMO
Strong heritage in pharmaceutical innovation and biotechnology.
Comprehensive range of services from early development to commercial supply.
Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.
All certificates
Replies slower than most
CDMO-CMO
Successfully inspected by TGA, PMDA, MHRA, ANVISA, Health Canada, MPA, IMB, & FDA
All facilities are in good standing with all regulatory authorities, including DEA, EPA, OSHA
Quality Management System and supporting analytical processes are almost 100% electronic
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+
ISO9001 certified
Drug R&D center (in Hangzhou)
From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
CDMO-CMO
Innovative approach to biomanufacturing and complex biologics.
Cutting-edge technology for next-generation therapies.
Strong focus on accelerating the development of transformative medicines.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1996
Production scale:
large
small
medium
Leading in biopharmaceutical development and biologic API production.
Comprehensive services from cell line development to commercial manufacturing.
Strong track record in delivering complex and high-quality biologics.
All certificates
Contact supplier
Not active
Looking for CMO/CDMO Services?
Find a list of providers specializing in CMOs/CDMOs Services for Biologics. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
CMO/CDMO - Contract (Development) Manufacturing Organizations
CDMOs and CMOs are pivotal in the pharmaceutical and biotech industries, offering specialized services in drug development and manufacturing. They assist in scaling up production from laboratory to commercial quantities, while adhering to strict regulatory standards. These organizations play a crucial role in the efficient and cost-effective production of medical and pharmaceutical products, ensuring quality and compliance at every stage.
Biologics
Biologics CMOs/CDMOs specialize in the manufacturing and development of biopharmaceutical products, which are typically derived from living organisms or biological sources such as proteins, antibodies, vaccines, and cell therapies.
Biologics Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) encompass specialists in the production and development of biopharmaceuticals. These products, often derived from living organisms or biological sources, include proteins, antibodies, vaccines, and cell therapies. This sector includes biologics manufacturers, biopharma CDMOs, and companies dedicated to biologics development and biologic drug manufacturing.
Key Services Provided by Our Listed Biologics CMOs/CDMOs:
Advanced Biopharmaceutical Manufacturing: Utilization of cutting-edge biomanufacturing processes for the production of biologics, ensuring high purity, efficacy, and safety. This includes comprehensive biologics manufacturing and contract manufacturing biologics services.
Custom Antibody and Protein Development: Expertise in developing a range of biologic products, including monoclonal antibodies and therapeutic proteins, tailored to specific therapeutic needs. This is a key focus for many biologics companies and CDMO biotech firms.
Vaccine Production: Specialization in the manufacturing of vaccines using advanced technologies, contributing to global health and disease prevention efforts. This is a critical service offered by CMO biologics and biologics CDMO list members.
Cell Therapy Development: Capability to develop and manufacture innovative cell therapies, offering new treatment possibilities in regenerative medicine and oncology. This is a rapidly growing area within biologics development.
Regulatory Expertise: In-depth knowledge of the regulatory environment governing biologics, ensuring compliance with standards set by agencies like the FDA and EMA. This expertise is vital for all aspects of biopharmaceutical manufacturing.
Your Partner in Biologics Development and Manufacturing
Pharmaoffer provides a platform to connect with CMOs/CDMOs specializing in biologics. Our category ensures easy access to organizations that are equipped with the expertise and technology required for the complex development and manufacturing processes of biopharmaceutical products.
